Gastrointestinal Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：125頁
文件格式：PDF
價 格：
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
The Gastrointestinal Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the Gastrointestinal Drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity Drugs, Antiemetics And Antinauseants, Antidiarrhoeals
Companies Mentioned: AbbVie, Johnson & Johnson, Takeda Pharmaceticals, Allergan, and UCB
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the Gastrointestinal Drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity Drugs, Antiemetics And Antinauseants, Antidiarrhoeals
Companies Mentioned: AbbVie, Johnson & Johnson, Takeda Pharmaceticals, Allergan, and UCB
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Gastrointestinal Drugs Market Characteristics;
2. Gastrointestinal Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Gastrointestinal Drugs Market Customer Information;
5. Gastrointestinal Drugs Market Segmentation;
5.1. Global Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals; 5.2. Global Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Gastrointestinal Drugs Market Trends And Strategies;
6. Gastrointestinal Drugs Market Regional And Country Analysis;
6.1. Global Gastrointestinal Drugs Market, 2016, By Region; 6.2. Global Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Gastrointestinal Drugs Market, 2016, By Country; 6.4. Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors;
7.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global;
8. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country;
9. Gastrointestinal Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Gastrointestinal Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Gastrointestinal Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Gastrointestinal Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Gastrointestinal Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Peptic Ulcer, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Gastrointestinal Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Gastrointestinal Drugs Market;
10.1.1. Asia-Pacific Gastrointestinal Drugs Market Overview; 10.1.2. Asia-Pacific Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.2. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis; 10.3. China Gastrointestinal Drugs Market; 10.3.1. China Gastrointestinal Drugs Market Overview; 10.3.2. China Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.3.3. China Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.3.4. China Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.3.5. China Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 10.4. India Gastrointestinal Drugs Market; 10.4.1. India Gastrointestinal Drugs Market Overview; 10.4.2. India Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.4.3. India Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.4.4. India Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.4.5. India Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 10.5. Japan Gastrointestinal Drugs Market; 10.5.1. Japan Gastrointestinal Drugs Market Overview; 10.5.2. Japan Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.5.5. Japan Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 10.6. Australia Gastrointestinal Drugs Market; 10.6.1. Australia Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.6.4. Australia Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
11. Western Europe Gastrointestinal Drugs Market;
11.1.1. Western Europe Gastrointestinal Drugs Market Overview; 11.1.2. Western Europe Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.2. Western Europe Gastrointestinal Drugs Market: Country Analysis; 11.3. UK Gastrointestinal Drugs Market; 11.3.1. UK Gastrointestinal Drugs Market Overview; 11.3.2. UK Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.3.3. UK Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.3.5. UK Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.4. Germany Gastrointestinal Drugs Market; 11.4.1. Germany Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.4.4 Germany Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.5 France Gastrointestinal Drugs Market; 11.5.1 France Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.5.2 France Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.5.3 France Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.5.4 France Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.6. Italy Gastrointestinal Drugs Market; 11.6.1. Italy Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.6.4. Italy Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.7. Spain Gastrointestinal Drugs Market; 11.7.1. Spain Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.7.4. Spain Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Gastrointestinal Drugs Market;
12.1.1. Eastern Europe Gastrointestinal Drugs Market Overview; 12.1.2. Eastern Europe Gastrointestinal Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Gastrointestinal Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 12.2. Eastern Europe Gastrointestinal Drugs Market: Country Analysis; 12.3. Russia Gastrointestinal Drugs Market; 12.3.1. Russia Gastrointestinal Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Gastrointestinal Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 12.3.4. Russia Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
13. North America Gastrointestinal Drugs Market;
13.1.1. North America Gastrointestinal Drugs Market Overview; 13.1.2. North America Gastrointestinal Drugs Historic Market, 2012 - 2016; 13.1.3. North America Gastrointestinal Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 13.2. North America Gastrointestinal Drugs Market: Country Analysis; 13.3. USA Gastrointestinal Drugs Market; 13.3.1. USA Gastrointestinal Drugs Historic Market, 2012 - 2016; 13.3.2. USA Gastrointestinal Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 13.3.4. USA Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
14. South America Gastrointestinal Drugs Market;
14.1.1. South America Gastrointestinal Drugs Market Overview; 14.1.2. South America Gastrointestinal Drugs Historic Market, 2012 - 2016; 14.1.3. South America Gastrointestinal Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 14.2. South America Gastrointestinal Drugs Market: Country Analysis; 14.3. Brazil Gastrointestinal Drugs Market; 14.3.1. Brazil Gastrointestinal Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Gastrointestinal Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 14.3.4. Brazil Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
15. Middle East Gastrointestinal Drugs Market;
15.1.1. Middle East Gastrointestinal Drugs Market Overview; 15.1.2. Middle East Gastrointestinal Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Gastrointestinal Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;;
16. Africa Gastrointestinal Drugs Market;
16.1.1. Africa Gastrointestinal Drugs Market Overview; 16.1.1. Africa Gastrointestinal Drugs Market Overview; 16.1.2. Africa Gastrointestinal Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Gastrointestinal Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;
17. Gastrointestinal Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Abbvie; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Johnson & Johnson; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Takeda Pharmaceuticals; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Allergan; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Ucb; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. Naics Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Gastrointestinal Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Gastrointestinal Drugs Market Customer Information;
5. Gastrointestinal Drugs Market Segmentation;
5.1. Global Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals; 5.2. Global Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Gastrointestinal Drugs Market Trends And Strategies;
6. Gastrointestinal Drugs Market Regional And Country Analysis;
6.1. Global Gastrointestinal Drugs Market, 2016, By Region; 6.2. Global Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Gastrointestinal Drugs Market, 2016, By Country; 6.4. Gastrointestinal Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors;
7.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global;
8. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country;
9. Gastrointestinal Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Gastrointestinal Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Gastrointestinal Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Gastrointestinal Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Gastrointestinal Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Peptic Ulcer, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Gastrointestinal Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Gastrointestinal Drugs Market;
10.1.1. Asia-Pacific Gastrointestinal Drugs Market Overview; 10.1.2. Asia-Pacific Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.2. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis; 10.3. China Gastrointestinal Drugs Market; 10.3.1. China Gastrointestinal Drugs Market Overview; 10.3.2. China Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.3.3. China Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.3.4. China Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.3.5. China Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 10.4. India Gastrointestinal Drugs Market; 10.4.1. India Gastrointestinal Drugs Market Overview; 10.4.2. India Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.4.3. India Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.4.4. India Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.4.5. India Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 10.5. Japan Gastrointestinal Drugs Market; 10.5.1. Japan Gastrointestinal Drugs Market Overview; 10.5.2. Japan Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.5.5. Japan Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 10.6. Australia Gastrointestinal Drugs Market; 10.6.1. Australia Gastrointestinal Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Gastrointestinal Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 10.6.4. Australia Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
11. Western Europe Gastrointestinal Drugs Market;
11.1.1. Western Europe Gastrointestinal Drugs Market Overview; 11.1.2. Western Europe Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.2. Western Europe Gastrointestinal Drugs Market: Country Analysis; 11.3. UK Gastrointestinal Drugs Market; 11.3.1. UK Gastrointestinal Drugs Market Overview; 11.3.2. UK Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.3.3. UK Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.3.5. UK Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.4. Germany Gastrointestinal Drugs Market; 11.4.1. Germany Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.4.4 Germany Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.5 France Gastrointestinal Drugs Market; 11.5.1 France Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.5.2 France Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.5.3 France Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.5.4 France Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.6. Italy Gastrointestinal Drugs Market; 11.6.1. Italy Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.6.4. Italy Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020; 11.7. Spain Gastrointestinal Drugs Market; 11.7.1. Spain Gastrointestinal Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Gastrointestinal Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 11.7.4. Spain Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Gastrointestinal Drugs Market;
12.1.1. Eastern Europe Gastrointestinal Drugs Market Overview; 12.1.2. Eastern Europe Gastrointestinal Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Gastrointestinal Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 12.2. Eastern Europe Gastrointestinal Drugs Market: Country Analysis; 12.3. Russia Gastrointestinal Drugs Market; 12.3.1. Russia Gastrointestinal Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Gastrointestinal Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 12.3.4. Russia Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
13. North America Gastrointestinal Drugs Market;
13.1.1. North America Gastrointestinal Drugs Market Overview; 13.1.2. North America Gastrointestinal Drugs Historic Market, 2012 - 2016; 13.1.3. North America Gastrointestinal Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 13.2. North America Gastrointestinal Drugs Market: Country Analysis; 13.3. USA Gastrointestinal Drugs Market; 13.3.1. USA Gastrointestinal Drugs Historic Market, 2012 - 2016; 13.3.2. USA Gastrointestinal Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 13.3.4. USA Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
14. South America Gastrointestinal Drugs Market;
14.1.1. South America Gastrointestinal Drugs Market Overview; 14.1.2. South America Gastrointestinal Drugs Historic Market, 2012 - 2016; 14.1.3. South America Gastrointestinal Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 14.2. South America Gastrointestinal Drugs Market: Country Analysis; 14.3. Brazil Gastrointestinal Drugs Market; 14.3.1. Brazil Gastrointestinal Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Gastrointestinal Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;; 14.3.4. Brazil Gastrointestinal Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Gastrointestinal Drugs Expenditure, 2012 - 2020;
15. Middle East Gastrointestinal Drugs Market;
15.1.1. Middle East Gastrointestinal Drugs Market Overview; 15.1.2. Middle East Gastrointestinal Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Gastrointestinal Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;;
16. Africa Gastrointestinal Drugs Market;
16.1.1. Africa Gastrointestinal Drugs Market Overview; 16.1.1. Africa Gastrointestinal Drugs Market Overview; 16.1.2. Africa Gastrointestinal Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Gastrointestinal Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Gastrointestinal Drugs Market, 2016, By Segment; Antacids; Antiulcerants; Vitamin And Minerals; Antiobesity Drugs; Antiemetics And Antinauseants; Antidiarrhoeals;
17. Gastrointestinal Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Abbvie; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Johnson & Johnson; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Takeda Pharmaceuticals; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Allergan; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Ucb; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. Naics Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
